Cheryl A. Conover
The Division of Endocrinology and Metabolism
Department of Medicine
Mayo Clinic
200 First Street SW
USA
Name/email consistency: high
- Longevity and age-related pathology of mice deficient in pregnancy-associated plasma protein-A. Conover, C.A., Bale, L.K., Mader, J.R., Mason, M.A., Keenan, K.P., Marler, R.J. J. Gerontol. A Biol. Sci. Med. Sci. (2010)
- Longevity is not influenced by prenatal programming of body size. Conover, C.A., Bale, L.K., Grell, J.A., Mader, J.R., Mason, M.A. Aging. Cell (2010)
- PAPP-A: a new anti-aging target? Conover, C.A. Aging. Cell (2010)
- Transgenic overexpression of pregnancy-associated plasma protein-A in murine arterial smooth muscle accelerates atherosclerotic lesion development. Conover, C.A., Mason, M.A., Bale, L.K., Harrington, S.C., Nyegaard, M., Oxvig, C., Overgaard, M.T. Am. J. Physiol. Heart Circ. Physiol. (2010)
- Differential regulation of pregnancy associated plasma protein-A in human coronary artery endothelial cells and smooth muscle cells. Conover, C.A., Harrington, S.C., Bale, L.K. Growth Horm. IGF Res. (2008)
- Insulin-like growth factor-binding proteins and bone metabolism. Conover, C.A. Am. J. Physiol. Endocrinol. Metab. (2008)
- Loss of pregnancy-associated plasma protein A extends lifespan in mice. Conover, C.A., Bale, L.K. Aging. Cell (2007)
- Surface association of pregnancy-associated plasma protein-A accounts for its colocalization with activated macrophages. Conover, C.A., Harrington, S.C., Bale, L.K., Oxvig, C. Am. J. Physiol. Heart Circ. Physiol. (2007)
- Cytokine stimulation of pregnancy-associated plasma protein A expression in human coronary artery smooth muscle cells: inhibition by resveratrol. Conover, C.A., Bale, L.K., Harrington, S.C., Resch, Z.T., Overgaard, M.T., Oxvig, C. Am. J. Physiol., Cell Physiol. (2006)
- Regulation of pregnancy-associated plasma protein-A expression in cultured human osteoblasts. Conover, C.A., Chen, B.K., Resch, Z.T. Bone (2004)
- Metalloproteinase pregnancy-associated plasma protein A is a critical growth regulatory factor during fetal development. Conover, C.A., Bale, L.K., Overgaard, M.T., Johnstone, E.W., Laursen, U.H., Füchtbauer, E.M., Oxvig, C., van Deursen, J. Development (2004)
- Role of extracellular matrix in insulin-like growth factor (IGF) binding protein-2 regulation of IGF-II action in normal human osteoblasts. Conover, C.A., Khosla, S. Growth Horm. IGF Res. (2003)
- Subcutaneous administration of insulin-like growth factor (IGF)-II/IGF binding protein-2 complex stimulates bone formation and prevents loss of bone mineral density in a rat model of disuse osteoporosis. Conover, C.A., Johnstone, E.W., Turner, R.T., Evans, G.L., John Ballard, F.J., Doran, P.M., Khosla, S. Growth Horm. IGF Res. (2002)
- Insulin-like growth factor (IGF) binding protein-3 potentiation of IGF action is mediated through the phosphatidylinositol-3-kinase pathway and is associated with alteration in protein kinase B/AKT sensitivity. Conover, C.A., Bale, L.K., Durham, S.K., Powell, D.R. Endocrinology (2000)
- In vitro studies of insulin-like growth factor I and bone. Conover, C.A. Growth Horm. IGF Res. (2000)
- Evidence that the insulin-like growth factor binding protein-4 protease in human ovarian follicular fluid is pregnancy associated plasma protein-A. Conover, C.A., Oxvig, C., Overgaard, M.T., Christiansen, M., Giudice, L.C. J. Clin. Endocrinol. Metab. (1999)
- Insulin-like growth factor I induction of c-myc expression in bovine fibroblasts can be blocked by antecedent insulin receptor activation. Conover, C.A., Bale, L.K. Exp. Cell Res. (1998)